Cargando…
Update of green tea interactions with cardiovascular drugs and putative mechanisms
Many patients treated with cardiovascular (CV) drugs drink green tea (GT), either as a cultural tradition or persuaded of its putative beneficial effects for health. Yet, GT may affect the pharmacokinetics and pharmacodynamics of CV compounds. Novel GT-CV drug interactions were reported for rosuvast...
Autores principales: | Werba, José Pablo, Misaka, Shingen, Giroli, Monica Gianna, Shimomura, Kenju, Amato, Manuela, Simonelli, Niccolò, Vigo, Lorenzo, Tremoli, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Food and Drug Administration
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326886/ https://www.ncbi.nlm.nih.gov/pubmed/29703388 http://dx.doi.org/10.1016/j.jfda.2018.01.008 |
Ejemplares similares
-
Effects of Mediterranean Diet or Low-Fat Diet on Blood Fatty Acids in Patients with Coronary Heart Disease. A Randomized Intervention Study
por: Giroli, Monica Gianna, et al.
Publicado: (2021) -
Impact of Green Tea Catechin Ingestion on the Pharmacokinetics of Lisinopril in Healthy Volunteers
por: Misaka, Shingen, et al.
Publicado: (2020) -
Exposure of Fexofenadine, but Not Pseudoephedrine, Is Markedly Decreased by Green Tea Extract in Healthy Volunteers
por: Misaka, Shingen, et al.
Publicado: (2022) -
Memantine has no effect on K(ATP) channels in pancreatic β cells
por: Imai, Ryota, et al.
Publicado: (2018) -
Trials in “True” Dyslipidemic Patients Are Urged to Reconsider Comprehensive Lipid Management as a Means to Reduce Residual Cardiovascular Risk
por: Werba, José P., et al.
Publicado: (2019)